logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
D

Dong‐Wan Kim

seoul national university

72H指数
730论文数
3.3W被引数
收录论文 115
发表时间
logo
In vitro evaluation of sacituzumab govitecan in non-small cell lung cancer with actionable genomic alterations在具有可操作基因组改变的非小细胞肺癌中体外评估sacituzumab govitecan
errTranslational Oncology
IF4.1
err2026-07-29
err0
errOAAI
errYerim Park; Soyeon Kim; Tae Min Kim; Miso Kim; Jeonghwan Youk; Dong-Wan Kim; Bhumsuk Keam
err分享
err收藏
Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trialReptrectinib治疗NTRK融合阳性的晚期实体瘤: 1/2期试验
errNature Medicine
IF50
err2026-02-04
err0
errOAAI
errBenjamin Besse; Jessica J. Lin; Lyudmila Bazhenova; Koichi Goto; Adrianus Johannes de Langen; Dong-Wan Kim; Jürgen Wolf; Christoph Springfeld; Sanjay Popat; Darren W. T. Lim; Misako Nagasaka; Jung Yong Hong; Christina S. Baik; Alice Hervieu; Victor Moreno; Nong Yang; Kanthi Kollengode; Haisu Yang; Yuanfang Xu; Christophe Y. Calvet; Yong Yuan; Amy B. Hammell; Alexander Drilon; Benjamin J. Solomon
err分享
err收藏
Harnessing reaction kinetics for wet chemical synthesis of Li-Si-Sb-S-I quinary Li-argyrodite solid electrolytes利用反应动力学指导湿化学合成Li-Si-Sb-S-I五元Li-argyrodite固态电解质
errChemical Engineering Journal
IF13.2
err2025-12-13
err0
PREAI
errSuk-Ho Hwang; Seung-Deok Seo; Hwanuk Yeo; Dong-Wan Kim
err分享
err收藏
MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancerMAGELLAN方案B1和B3臂：在治疗初治转移性非小细胞肺癌患者中，比较度伐利尤单抗联合化疗与联合化疗并联合奥雷oclumab的疗效。
errLung Cancer
IF4.4
err2025-11-07
err0
PREAI
errByoung Chul Cho; Chaiyut Charoentum; Dong-Wan Kim; Cheng-Ta Yang; Rafal Dziadziuszko; Sarayut Lucien Geater; Helen Mann; Banafsheh Afshar-Imani; Pavlo Lyfar; James Chih-Hsin Yang; Sandip Pravin Patel
err分享
err收藏
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and leptomeningeal metastases: The KCSG LU 21-01, LAZARUS study拉泽替尼联合培美曲塞治疗表皮生长因子受体突变阳性非小细胞肺癌合并软脑膜转移的II期研究：KCSG LU 21-01、LAZARUS研究
errLung Cancer
IF4.4
err2025-11-01
err0
PREAI
errHyun-Ae Jung; Tae Min Kim; Hye Ryun Kim; Chang Gon Kim; Hee Kyung Ahn; Youngjoo Lee; Yu Jung Kim; Miso Kim; Jeonghwan Youk; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Dong-Wan Kim; Myung-Ju Ahn; Bhumsuk Keam
err分享
err收藏
\zaAlectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: Final overall survival analysis of the Phase III ALEX study阿来替尼对比克唑替尼用于初治ALK阳性晚期非小细胞肺癌：III期ALEX研究最终总生存期分析
errAnnals of Oncology
IF65.4
err2025-10-17
err0
errOAAI
errS. Peters; R. Camidge; R. Dziadziuszko; S. Gadgeel; A.T. Shaw; D-W. Kim; M. Pérol; D.R. Rosell; P. Cheema; D.Wan-Teck Lim; J.J. Lin; N. Pavlakis; J.S. Ahn; L. Zhang; V. Henschel; A.A. Higgerson; V. McNally; I. Rooney; A. Scalori; V. Smoljanovic; T. Mok
err分享
err收藏
A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24)一项关于度鲁木单抗、多柔比星和异环磷酰胺用于复发性/或转移性肺肉瘤样癌的II期研究（KCSG LU-19-24）
errClinical Lung Cancer
IF3.3
err2025-10-11
err0
PREAI
errMiso Kim; Jeonghwan Youk; Tae Min Kim; Gyeong-Won Lee; Dong-Wan Kim; Bhumsuk Keam
err分享
err收藏
The Synergistic Effect of PARP Inhibitors and Irinotecan in Small Cell Lung Cancer CellsPARP抑制剂与伊立替康在小型细胞肺癌细胞中的协同效应
errCANCER RESEARCH AND TREATMENT
IF3.8
err2025-10-01
err0
errOAAI
errOh, Songji; Kim, Soyeon; Keam, Bhumsuk; Youk, Jeonghwan; Kim, Tae Min; Kim, Dong-Wan; Kim, Miso
err分享
err收藏
Final analysis results and patient-reported outcomes from DESTINY-Lung02—a dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic non–small cell lung cancer最终分析结果和患者报告结局来自DESTINY-Lung02——一项关于曲妥珠单抗德鲁替康在HER2突变型转移性非小细胞肺癌患者中的剂量盲法、随机、II期研究
errJournal of Thoracic Oncology
IF20.8
err2025-07-30
err0
PREAI
errPasi A. Jänne; Yasushi Goto; Toshio Kubo; Kiichiro Ninomiya; Sang-We Kim; David Planchard; Myung-Ju Ahn; Egbert Smit; Adrianus Johannes de Langen; Maurice Pérol; Elvire Pons-Tostivint; Silvia Novello; Hidetoshi Hayashi; Junichi Shimizu; Dong-Wan Kim; Kaline Pereira; Fu-Chih Cheng; Ayumi Taguchi; Yingkai Cheng; Kyle Dunton; Ahmed Ali; Koichi Goto
err分享
err收藏
First-Line Lorlatinib Versus Crizotinib in Asian Patients With Advanced ALK-Positive NSCLC: Five-Year Outcomes From the CROWN Study亚洲晚期ALK阳性NSCLC患者中，劳拉替尼一线治疗与克唑替尼的对比：CROWN研究五年结果
errJournal of Thoracic Oncology
IF20.8
err2025-02-28
err0
errOAAI
errYi-Long Wu; Hye Ryun Kim; Ross A. Soo; Qing Zhou; Hiroaki Akamatsu; Gee-Chen Chang; Chao-Hua Chiu; Hidetoshi Hayashi; Sang-We Kim; Yasushi Goto; Terufumi Kato; Jianying Zhou; Victor Ho-Fun Lee; Makoto Nishio; Baohui Han; Dong-Wan Kim; Shun Lu; Anna Polli; Jean-François Martini; Francesca Toffalorio; Tony Mok
err分享
err收藏
Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications
errESMO OPEN
IF8.3
err2025-01-01
err0
PREAI
errPark, C.; Kim, R.; Bae, J. M.; Lee, T.; Song, S.; Kwak, Y.; Lee, K. B.; Youk, J.; Keam, B.; Kim, T. M.; Kim, D. -w.; Kim, J. -i.; Choi, J.; Kim, M.
err分享
err收藏
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study通过分子改变选择的实体瘤患者的sitratinib: Ib期研究的结果
errFUTURE ONCOLOGY
IF2.6
err2024-11-08
err0
errOAAI
errBazhenova, Lyudmila; Kim, Dong-Wan; Cho, Byoung Chul; Goel, Sanjay; Heist, Rebecca; Werner, Theresa L.; Eaton, Keith D.; Wang, Judy S.; Pant, Shubham; Adkins, Douglas R.; Blakely, Collin M.; Yan, Xiaohong; Neuteboom, Saskia; Christensen, James G.; Chao, Richard; Bauer, Todd
err分享
err收藏
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study1/2期LASER201研究中使用拉泽替尼治疗的EGFR T790M-positive晚期非小细胞肺癌患者的更新的总生存期和ctDNA分析
errBMC MEDICINE
IF8.3
err2024-10-08
err0
errOAAI
errHan, Ji-Youn; Ahn, Myung-Ju; Lee, Ki Hyeong; Lee, Yun-Gyoo; Kim, Dong-Wan; Min, Young Joo; Kim, Sang-We; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Sung Sook; Lee, Na Mi; Jang, Hyun Woo; Han, Heewon; Park, Hyejoo; Lee, Jieon; Cho, Byoung Chul
err分享
err收藏
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer简明语言总结: 劳拉替尼与克唑替尼在非小细胞肺癌中的CROWN研究的5年结果
errFUTURE ONCOLOGY
IF2.6
err2024-10-03
err0
errOAAI
errSolomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross A.; Mazieres, Julien; Shaw, Alice T.; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd M.
err分享
err收藏
Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-09-01
err1
PREAI
errPark, Siyeon; Park, Seongyeol; Kim, Tae Min; Kim, Soyeon; Koh, Jaemoon; Lim, Joonoh; Yi, Kijong; Yi, Boram; Ju, Young Seok; Kim, Miso; Keam, Bhumsuk; Kim, Jung Sun; Jeon, Yoon Kyung; Kim, Dong-Wan; Kim, Young Tae; Heo, Dae Seog
err分享
err收藏
Transcriptomic Heterogeneity of EGFR-Mutant Non-Small Cell Lung Cancer Evolution Toward Small-Cell Lung CancerEGFR突变非小细胞肺癌向小细胞肺癌进化的转录组异质性
errCLINICAL CANCER RESEARCH
IF10.2
err2024-08-16
err0
PREAI
errOh, Songji; Koh, Jaemoon; Kim, Tae Min; Kim, Soyeon; Youk, Jeonghwan; Kim, Miso; Keam, Bhumsuk; Jeon, Yoon Kyung; Ku, Ja-Lok; Kim, Dong-Wan; Chung, Doo Hyun; Heo, Dae Seog
err分享
err收藏
Synergistic effects of EZH1/2 dual inhibition and cisplatin on lung cancer cell lines with loss of SMARCA4 and SMARCA2
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errLee, Jeongjae; Keam, Bhumsuk; Kim, Soyeon; Youk, Jeonghwan; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Seog, Heo Dae
err分享
err收藏
Characterization of the phylogenetic relationships in bilateral breast angiosarcoma
errCANCER RESEARCH
IF16.6
err2024-03-22
err0
PREAI
errKim, Minju; Youk, Jeonghwan; Kim, Soyeon; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Song, Myung Geun; Koh, Jiwon; Bae, Jeong Mo; Moon, Hyeong-Gon; Im, Seock-Ah
err分享
err收藏
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial生物标志物定向靶向治疗联合durvalumab治疗晚期非小细胞肺癌: 2期伞形试验
errNATURE MEDICINE
IF50
err2024-02-13
err10
errOAAI
errBesse, Benjamin; Pons-Tostivint, Elvire; Park, Keunchil; Hartl, Sylvia; Forde, Patrick M.; Hochmair, Maximilian J.; Awad, Mark M.; Thomas, Michael; Goss, Glenwood; Wheatley-Price, Paul; Shepherd, Frances A.; Florescu, Marie; Cheema, Parneet; Chu, Quincy S. C.; Kim, Sang-We; Morgensztern, Daniel; Johnson, Melissa L.; Cousin, Sophie; Kim, Dong-Wan; Moskovitz, Mor T.; Vicente, David; Aronson, Boaz; Hobson, Rosalind; Ambrose, Helen J.; Khosla, Sajan; Reddy, Avinash; Russell, Deanna L.; Keddar, Mohamed Reda; Conway, James P.; Barrett, J. Carl; Dean, Emma; Kumar, Rakesh; Dressman, Marlene; Jewsbury, Philip J.; Iyer, Sonia; Barry, Simon T.; Cosaert, Jan; Heymach, John V.
err分享
err收藏
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusionsI/II期eNRGy试验: Zenocutuzumab在携带NRG1基因融合的癌症患者中
errFUTURE ONCOLOGY
IF2.6
err2024-02-13
err20
errOAAI
errKim, Dong-Wan; Schram, Alison M.; Hollebecque, Antoine; Nishino, Kazumi; Macarulla, Teresa; Rha, Sun Young; Duruisseaux, Michael; Liu, Stephen, V; Al Hallak, Mohammed Najeeb; Umemoto, Kumiko; Wesseler, Claas; Cleary, James M.; Springfeld, Christoph; Neuzillet, Cindy; Joe, Andrew; Jauhari, Shekeab; Ford, Jim; Goto, Koichi
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
P
Pasi A. Jänne
H 指数: 163 · 论文数: 2.3K
J
James Chih‐Hsin Yang
H 指数: 141 · 论文数: 1.2K
Y
Yi‐Long Wu
H 指数: 135 · 论文数: 2.2K
R
Roy S. Herbst
H 指数: 134 · 论文数: 1.3K
C
Charles M. Rudin
H 指数: 132 · 论文数: 1.7K
查看更多